key: cord-0808993-4kwwkn61
authors: Obermayer, Astrid; Jakob, Lisa-Maria; Haslbauer, Jasmin D.; Matter, Matthias S.; Tzankov, Alexandar; Stoiber, Walter
title: Neutrophil Extracellular Traps in Fatal COVID-19-Associated Lung Injury
date: 2021-07-30
journal: Dis Markers
DOI: 10.1155/2021/5566826
sha: 0c7a837fd4b450c96400a3ebb1362edb4e4a389f
doc_id: 808993
cord_uid: 4kwwkn61

An excess formation of neutrophil extracellular traps (NETs), previously shown to be strongly associated with cytokine storm and acute respiratory distress syndrome (ARDS) with prevalent endothelial dysfunction and thrombosis, has been postulated to be a central factor influencing the pathophysiology and clinical presentation of severe COVID-19. A growing number of serological and morphological evidence has added to this assumption, also in regard to potential treatment options. In this study, we used immunohistochemistry and histochemistry to trace NETs and their molecular markers in autopsy lung tissue from seven COVID-19 patients. Quantification of key immunomorphological features enabled comparison with non-COVID-19 diffuse alveolar damage. Our results strengthen and extend recent findings, confirming that NETs are abundantly present in seriously damaged COVID-19 lung tissue, especially in association with microthrombi of the alveolar capillaries. In addition, we provide evidence that low-density neutrophils (LDNs), which are especially prone to NETosis, contribute substantially to COVID-19-associated lung damage in general and vascular blockages in particular.

Since the first published reports on clinical features of COVID-19 (e.g., [1] ), there is cumulative evidence that critical cases could be substantially aggravated by the tissue-damaging effects of neutrophil extracellular DNA traps (NETs) [2] . Likely associated with a cytokine storm [3] [4] [5] , critically ill COVID-19 patients were shown to develop conditions that had all been previously identified as closely associated with NETosis (a topic introduced by Barnes et al. [6] and Mozzini and Girelli [7] ) such as severe tissue injury, coagulopathy, and barrier dysfunction of the lungs [8] . A copious release of proinflammatory peptides causing a cytokine storm, as seen in COVID-19 [9] , has long been regarded as a potent inductor of NETosis (e.g., [10] ).

Present evidence indicates that severe COVID-19 is a specific acute respiratory distress syndrome (ARDS) phenotype frequently showing diffuse alveolar damage (DAD) and presenting with endothelial dysfunction and a hypercoagulable state [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Previous studies have delineated a central role of NETs in alveolar and vascular damage in ARDS of other etiologies and other inflammatory pulmonary diseases [23, 24] and to intravascular clotting and thrombosis [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , indicating a likely pathophysiological association between NETosis and ARDS.

ARDS of various etiologies had previously been shown to be accompanied with elevated serum levels of D-dimers [36] , yet considerably less pronounced than in COVID-19, and cell-free DNA [35] , both shown to be strongly associated with NETosis (e.g., [37] ). A potential link between systemic NETosis and endothelial dysfunction leading to microvascular coagulation in COVID-19 is therefore highly probable. In line with this, COVID-19 sera were found to contain abundant NETosis markers such as cell-free DNA, myeloperoxidase-(MPO-) associated DNA, and citrullinated histone H3 (citH3), together with elevated levels of the acute-phase C-reactive protein (CRP) and D-dimer [38, 39] . Initial immunohistochemical data further substantiated a role of NETosis in COVID-19-associated lung injury and thromboembolic complications [40] [41] [42] . Based on this evidence, the potential influential role of NETs and their by-products in COVID-19 pathogenesis and outcome is now rapidly gaining acceptance and has also been considered in treatment approaches in COVID-19 such as anti-IL6 and IL26 therapy (e.g., [5, [43] [44] [45] ).

This study intends to strengthen and expand upon the above findings. We used immunolabeling together with histochemical staining to trace the NET-forming cells, NETs, and their molecular markers in autopsy lung tissue from seven COVID-19 patients. Stereological point counting was employed to quantify citH3+ NETs and citH3+ neutrophils in these tissues, also to enable comparison with NETosis levels in specimens of non-COVID-19 bacterial pneumonia and DAD, and in healthy control lungs.

All autopsies were performed at the Institute of Pathology, University Hospital of Basel, Switzerland, according to previously delineated safety protocols [18] . COVID-19 lungs were tracheally perfused with 4% phosphate-buffered formalin (72 hrs. at room temperature) and cut into 0.5-1 cm parasagittal slices. Samples for histological analysis were extracted from the periphery and centers of each lobe and subsequently dehydrated and embedded in paraffin. The present investigation was undertaken on a tissue macroarray of seven samples selected from superior lobes of well-characterized COVID-19 patients (patient nos. 1 to 7 of the cohort of Menter et al. [18] , 2 females and 5 males, age 68-96 years; Table 1 ). The tissue macroarray was constructed by dissecting equilateral triangular fragments of 0.5 cm (i.e., 0.108 cm 2 ) from paraffin-embedded lung tissue containing typical sequelae of COVID-19 and transferring these fragments to a recipient block, in a manner analogous to that described by Battifora [46] . Tissue microarray cores with 1 mm diameter from age-matched patients, who died of pneumonia and ARDS due to other causes than COVID-19, were used for quantitative evaluation of citH3+ NETs and neutrophils. These reference specimens included 5 cases of bacterial (Streptococcus pneumoniae) pneumonia [47] and 5 cases of non-COVID-19-related DAD [48] , as well as 5 reference control lungs without pathology.

Immunohistochemistry was performed for the neutrophilic enzyme MPO, the chromatin decondensation marker citH3, the carcinoembryonic antigen-related cell adhesion molecule CD66b, and the glycan determinant CD15/Lewis x, a distinguishing marker of human myeloid cells, the latter two reported as highly expressed in low-density neutrophils (LDNs) [49] . The following primary antibodies were used: Ultra autostainer (with MPO and CD15) and AP-conjugated goat anti-rabbit IgG (ab97048, Abcam, UK; with citH3 and CD66b) were used for secondary visualization. Histochemical Prussian-blue staining (Perls' stain) was used to identify macrophages with endogenous iron (hemosiderin) deposits. Hematoxylin (with MPO and CD15), Feulgen-Rossenbeck reaction (with citH3 and CD66b), and nuclear fast red (with Prussian blue) were used as nuclear/DNA counterstains.

Quantification of citH3+ NETs and citH3+ cells with still intact nuclei (the latter being assumed to be neutrophils induced to NETosis) was performed by stereological point counting using ImageJ software. Random nonoverlapping microscopic fields (final size 565 × 433 μm = 244:65 mm 2 ) Disease Markers were taken from the citH3-Feulgen double-stained macroarray specimens (5 fields per specimen) and from the similarly stained reference specimens (see above). Microscopic fields were digitally overlaid with a regular 10 × 10 μm square array test system; array crosspoints falling on the target structures were counted and used to calculate area fractions. A nonparametric Kruskal-Wallis test was used to evaluate intergroup differences.

2.1. Ethical Approval. The work was conducted in cooperation of both institutions and was approved by the Ethics Committee of Northwestern and Central Switzerland (Ethikkommission Nordwest-und Zentralschweiz), Project-ID 2020-00969, decision of May 19 th , 2020 (formal letter in German).

Immunohistochemical analyses for all NETosis markers produced variable results between tissue samples of different patients and demonstrated that signals were not restricted to the producer cells but also present at sites of secondary dissemination. Immunostaining for MPO demonstrated an extensive neutrophil infiltration mainly in the interalveolar septal space. With some variation in incidence between samples, scattered MPO+ cells were detected on alveolar surfaces and alveolar lumens and clumped and/or arranged along the inner lining of the capillary endothelium and other small vessels (Figure 1(a) ). Large numbers of MPO+ cellular aggregates were found in and associated with areas of proliferative diffuse alveolar damage (DAD) in particular (Figures 1(b) and 1(k)). Ample deposits of hyaline membrane (asterisks in Figure 1 (c)) were usually less densely populated. In some areas, MPO+ cells appeared spread out, with large oval cell bodies and speckled and/or reticulate inclusions partly costaining for DNA (arrow in Figure 1 (d), detail in Figure 1 (e)). In focal and/or patchy patterns, MPO-stained particles were also observable at extracellular sites. MPO signals were found at various sites in the parenchyma in fine granular deposits or fibrous meshworks, frequently associated with alveolar surfaces and inner linings of alveolar septa and capillaries, displaying an eroded appearance (Figures 1(f) and 1(i)), and cemented between MPO+ cells in microthrombi (Figures 1(g)-1(k) ). From previous investigations [50, 51] , we postulate that these formations are the histomorphological correlate of NETs. Similar to MPO+ cells, deposits in hyaline membranes were hardly interspersed with MPO+ fibrous matter.

Staining patterns for citH3 were broadly in accordance with those for MPO (and also with those described for e)). In agreement with the MPO and CD66b staining patterns, citH3 was frequently also found in fine granular and/or fibrous extracellu-lar structures and often associated with the DNA stain, thus corroborating our assumption that these structures represent NETs (asterisks in Figures 2(f)-2(h)). As with MPO, NETosis demonstrated a patch-like distribution, additionally found inside of and interspersed with the constituents of thrombi (asterisk in Figure 2 (e)). A particularly high presence of intra-and extracellular citH3 was similarly seen in proliferative DAD (Figure 2(h) ).

Results of the quantification of citH3+ NETs and neutrophils indicated a clearly higher prevalence of both target variables in COVID-19 lungs as compared to Pneumococcus pneumonia and non-COVID-19 DAD (p4, lines 139-144, and Figures 2(i) and 2(j)). Differences are statistically significant between COVID-19 and bacterial pneumonia for citH3 + NETs, between COVID-19 and non-COVID-19 DAD for citH3+ cells with still intact nuclei, and between COVID-19 and control lungs devoid of pathology for both target variables (p < 0:05 each).

Large amounts of cells in all samples stained positively for CD66b and CD15. Many cells intensely expressing these granulocyte markers likely represent LDNs that are strongly prone to NETosis [49] . Localization and distribution of CD66b+ and CD15+ cells mirrored the patterns described for MPO+ cells, being particularly present in alveolar walls and spaces (Figures 3(a), 3(b) , 3(e), 3(h), and 3(k)), in and around blood vessels (Figures 3(c), 3(d) , 3(f), 3(j), 3(k), and 3(l)), in NET-associated thrombi (Figures 3(c) , 3(f), and 3(l)), and occasionally in alveolar spaces (Figure 3(e) ). The largest conglomeration of CD66+ cells was also here found in samples of proliferative DAD (Figures 3(f) and 3(m) ). Extracellular staining for CD66b and CD15 was abundant, with patterns largely conforming to those of MPO, i.e., showing diffuse or fibrous inclusions in blood vessels and alveolar walls (arrows in Figures 3(f) , 3(i), and 3(j)) and roundish patches of speckled or reticulate matter (Figures 3(g) and 3(n)) comparable to the diffuse remnants of MPO+ neutrophils (cf. Figures 1(d) and 1(e) ). Some blood clots consisted almost exclusively of strongly CD66b+ or CD15+ cells (i.e., presumed LDNs), partly intermingled with extracellular substance similarly exhibiting positivity for one of these markers (Figures 3(f) and 3(l) ).

Six of the seven samples additionally contained relevant numbers of cells of different sizes that stained with Prussian blue (Perls' stain). Large Prussian blue-stained cells mainly formed loose groups or clusters in alveoli (Figures 4(a)-4(c) ), but single cells also were detected in interalveolar spaces and adjacent to blood vessels (Figure 4(d) ). Prussian blue-stained granules were also observed in roundish patches that bore resemblance to outspread neutrophils ( (Figures 4(h) and 4(i)). Such granules were also found intermingled with extracellular substances, probably including areas of released NETs (Figure 4(g) ).

In accordance with previous analyses of COVID-19 lungs (e.g., [40] ), immunohistochemistry revealed neutrophilic 3(m) ). The relevance of the latter might not only be seen in a detrimental inflammatory context but also in the light of findings in ARDS of other etiologies, such as acid-induced lung injury, indicating that neutrophils promote alveolar epithelial regeneration via enhancement of type II pneumocyte proliferation [52] . Current evidence suggests that the negative effects of NETs will far outweigh any possible benefit. Indeed, immunostaining for MPO, citH3, CD66b, and CD15 unambiguously demonstrates an abundant presence of NETs and NET-generating neutrophils at sites of alveolar damage (e.g., Figure 1 Fig. S1 in Supplementary materials). A state of detrimentally enhanced NETosis seems to be also mirrored in the serological data before death (Table 1) , particularly by the high levels of CRP and lactate dehydrogenase (LDH) (role in NETosis addressed by [53] ), and strong neutrophilia in four of the seven patients.

Together, this clearly substantiates our initial hypothesis that COVID-19-associated DAD and DAD in general [23, 54] and for bacterial pneumonia [32, 55] . However, the present morphological findings together with the results of the comparative quantitative analysis of citH3 (Figures 2(i) and 2(j)) point toward potentially more drastic adverse effects of NETosis in COVID-19. Implications of the present results for COVID-19 thromboinflammatory pathology seem to be multifaceted. Our current observations provide important further support of previous findings in COVID-19 patients revealing DAD with particular signs of vascular dysfunction in lungs and other organs [13, [16] [17] [18] . Validation that the microvascular thromboses seen are not simply cadaveric clots (cruor sanguinis) but true microthrombi comes from the finding that these formations contain well-formed, intensively immunopositive fibrin casts of 5-20 μm in dimension [18] and from broad clinical evidence of thrombotic microangiopathy even in nonlethal COVID-19 [56] . Although microthrombosis is not an exclusive feature of COVID-19 but a potential complication of DAD in general, results from our research indicate a much higher prevalence of such microthrombi in COVID-19. A previous study on the same cohort found a ninefold increase of alveolar capillary microthrombi per standard area of injured lung tissue in the same 7 COVID-19 patients compared to influenza patients [17] . Together with several lines of evidence from the literature (e.g., summarized by [12] ), this supports the conclusion that COVID-19 is Figure 3 : Immunostaining for the low-density neutrophilic (LDN) markers CD66b (dark blue (a-g)) and CD15 (brown (h-n)), DNA/nuclei counterstained with Feulgen method (purple (a-g)) and hematoxylin (blue (h-n)). Disease Markers associated with a more specific form of DAD characterized by extreme hypercoagulability.

Our current study provides evidence that some microthrombi in COVID-19 consist almost entirely of citH3+, CD66b+, and CD15+ cells (Figures 2(d) and 2(e) and Figures 3(e) , 3(f), 3(k), and 3(l)) and points to an instrumental role of strongly NETosis-prone LDNs in COVID-19 vascular clotting. The finding confirms and further specifies related results of Jiménez-Alcázar et al. [57] , Middleton et al. [41] , and Leppkes et al. [40] . Evidence from cancer research suggests that LDNs represent a mixture of immature and mature variants in proportions contextually varying with diseases [58, 59] . It has been proposed that immature LDNs are in fact a class of myeloid-derived suppressor cells able to interfere with T cell-mediated immune responses, while mature LDNs are converted from normal density neutrophils (NDNs) by a mechanism depending on host and/or pathogen-derived factors, thereby similarly acquiring immunosuppressive qualities [58, 60] . As shown in tuberculosis, LDN-derived NETs may induce a vicious cycle by means of increased NDN-to-LDN conversion [61] . Recent synoptic analysis suggests a considerable pathophysiological role of human LDNs in a plethora of conditions, such as acute and chronic infections, inflammation, cancer, and pregnancy [62] . The role of LDN-derived NETs in COVID-19 thus warrants further investigation.

Large Prussian blue-stained cells (Figures 4(a) -4(c) and 4(e)) are in all probability hemosiderin-laden macrophages. Their presence is consistent with findings from analysis of bronchoalveolar lavages (BAL) from COVID-19 patients [63] . Together with the presence of hemosiderin granules in presumably NET-forming neutrophils (Figures 4(e)-4(g)) and other mobile cells (Figure 4 (i)), and at various extracellular sites, this may prompt considerations about the scope of SARS-CoV-2-induced damage on erythrocyte hemoglobin. Indeed, alveolar macrophages (and likely other phagocytes) collecting free iron ions derive from iron displacement from the heme porphyrin [63] [64] [65] . As a caveat, clustered large Prussian blue+ cells bear remarkable similarity to giant (pseudo-)syncytia also occurring in COVID-19 lungs. These were recently classified as of pneumocyte origin due to their staining for surfactant-A, thyroid transcription factor 1, and napsin A [66] . Relations with iron ion uptake remain to be determined.

Sampling. Careful inspection of the chosen COVID-19 tissue samples together with the use of a macroarray of comparably large fragments as opposed to conventional tissue microarray cores (usually 1 mm in diameter, i.e., 0.785 mm 2 ) as well as punching control tissues in triplicates served to prevent confounding of the obtained results due to tissue microheterogeneity.

Overall, our immunomorphological findings confirm and considerably expand upon the recent histopathological findings on NETosis in COVID-19 lungs. NETs are abundantly 7 Disease Markers present in respective seriously damaged respiratory tissue and thrombotic vascular occlusions, unbiased by formalin autofluorescence. Our results also clearly support a relevant contribution of LDNs to COVID-19 pathophysiology, with an emphasis on vascular blockage and microthrombus formation. Further elucidation of the underlying mechanisms allows for a more diversified understanding of neutrophil heterogeneity and effects of COVID-19 immune dysregulation.

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.

As a supplement, we provide a panel of three as yet unpublished images (Figs. S1A-C) from scanning and transmission electron microscopy (SEM and TEM, respectively) taken in the course of our previous research employing in vitro induction of NETs [51] . The images document that human neutrophils releasing NETs after stimulation with phorbol myristate acetate (PMA) bear a close morphological resemblance to the large oval-shaped cells filled with reticulate matter staining for NETosis-related marker proteins and DNA that we show in Figures 1(d) and 1(e) and Figures 3(g) and 3 (n). The SEM images (Figs. S1A,B) show an irregularly rounded patch of NETs encircling the still compact remains of its cell-oforigin (S1A), and the remains of a neutrophil in a further advanced stage of NETosis, with thin NET strands projecting radially outward and being bundled into a tail-like extension (S1B). The TEM image (Fig. S1C) was taken from an 80 nm horizontal section through a cell similar to that in Fig. S1A . The cell shows a largely intact outer membrane and a still recognisable nucleus with a partly preserved nuclear membrane. Decondensed chromatin is present in the cytoplasm. Threads of NETs decorated with vesicles attach to and project from the cell's surface. (Supplementary Materials) 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Neutrophil extracellular traps kill bacteria

SARS-CoV-2, the virus that causes COVID-19: cytometry and the new challenge for global health

The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndromelike disease

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

Targeting potential drivers of COVID-19: neutrophil extracellular traps

The role of neutrophil extracellular traps in Covid-19: only an hypothesis or a potential new field of research?

Neutrophil extracellular traps -the dark side of neutrophils

COVID-19 cytokine storm: the anger of inflammation

Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition

Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study

The pulmonary pathology of COVID-19

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases

COVID-19 and the cardiovascular system

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia

Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19

Postmortem examination of COVID-19 patients reveals diffuse alveolar variegated findings in lungs and other organs suggesting vascular dysfunction

Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction

Coronavirus disease 2019 (COVID-19): a clinical update

2019-novel coronavirus severe adult respiratory distress syndrome in two cases in Italy: an uncommon radiological presentation

Imaging profile of the COVID-19 infection: radiologic findings and literature review

Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis

NET balancing: a problem in inflammatory lung diseases

Neutrophil extracellular trap (NET) impact on deep vein thrombosis

Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo

The emerging role of neutrophils in thrombosis-the journey of TF through NETs

VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice

Thrombosis: tangled up in NETs

NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation

Reactive oxygen species in venous thrombosis

Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia

The emerging role of neutrophil extracellular traps in respiratory disease

NETs promote ALI/ARDS inflammation by regulating alveolar macrophage polarization

Understanding the role of neutrophil extracellular traps in patients with severe pneumonia and ARDS

Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome

Circulating DNAs, a marker of neutrophil extracellular traposis and cancerrelated stroke

Neutrophil extracellular traps in COVID-19

D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review

Vascular occlusion by neutrophil extracellular traps in COVID-19

Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study

Neutrophil extracellular traps and by-products play a key role in COVID-19: pathogenesis, risk factors, and therapy

Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19

Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome

The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing

Characterization of the inflammatory infiltrate in Streptococcus pneumoniae pneumonia in young and elderly patients

Retrospective post-mortem SARS-CoV-2 RT-PCR of autopsies with COVID-19-suggestive pathology supports the absence of lethal community spread in

Phenotypic and clinical characterization of low density neutrophils in patients with advanced lung adenocarcinoma

NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis

Disease Markers

New aspects on the structure of neutrophil extracellular traps from chronic obstructive pulmonary disease and in vitro generation

Neutrophils promote alveolar epithelial regeneration by enhancing type II pneumocyte proliferation in a model of acid-induced acute lung injury

CRP induces NETosis in heart failure patients with or without diabetes

High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza A infection

Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury

Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: a review article

Host DNases prevent vascular occlusion by neutrophil extracellular traps

Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer

Neutrophil heterogeneity: bona fide subsets or polarization states?

Neutrophil and granulocytic myeloid-derived suppressor cell-mediated T cell suppression significantly contributes to immune dysregulation in common variable immunodeficiency disorders

Mycobacterium tuberculosis infection induces low-density granulocyte generation by promoting neutrophil extracellular trap formation via ROS pathway

Neutrophil diversity in health and disease

Detection of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of COVID-19 patients: is Perls stain a potential indicator of oxidative alveolar damage?

COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review

Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel coronavirus disease 2019 (COVID-19) and its complications

Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology

Disease Markers

This work was supported by the Botnar Research Centre for Child Health (BRCCH) Basel.

The authors declare that there is no conflict of interest regarding the publication of this article.

Alexandar Tzankov and Walter Stoiber contributed equally to this work.